It was a puzzling phenomenon that we failed to observe any correlations of either p-Stat3 activities or IL-17 levels with clinicopathological characteristics among these CRC patients including cell differentiation, metastasis, clinical staging among others analyzed (Table 5). The gene discussed is STAT3; the disease is colorectal carcinoma.